Created at Source Raw Value Validated value
Nov. 26, 2021, 10:30 p.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Hetero-Tocilizumab: Hetero-Tocilizumab 8mg/kg (maximum 800mg) once on Day 1. This is a single dose administration intravenously over 60 min infusionControl Intervention1: RMP-Tocilizumab: RMP-Tocilizumab 8mg/kg (maximum 800mg) once on Day 1. This is a single dose administration intravenously over 60 min infusion", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Hetero-Tocilizumab: Hetero-Tocilizumab 8mg/kg (maximum 800mg) once on Day 1. This is a single dose administration intravenously over 60 min infusion", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: RMP-Tocilizumab: RMP-Tocilizumab 8mg/kg (maximum 800mg) once on Day 1. This is a single dose administration intravenously over 60 min infusion", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "Hetero-tocilizumab", "treatment_id": 1299, "treatment_name": "Tocilizumab", "treatment_type": "Interleukin inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "RMP-tocilizumab", "treatment_id": 1299, "treatment_name": "Tocilizumab", "treatment_type": "Interleukin inhibitors", "pharmacological_treatment": "Pharmacological treatment"}]

Nov. 13, 2021, 5:33 p.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

May 27, 2021, 12:45 a.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Hetero-Tocilizumab: Hetero-Tocilizumab 8mg/kg (maximum 800mg) once on Day 1. This is a single dose administration intravenously over 60 min infusionControl Intervention1: RMP-Tocilizumab: RMP-Tocilizumab 8mg/kg (maximum 800mg) once on Day 1. This is a single dose administration intravenously over 60 min infusion", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Hetero-Tocilizumab: Hetero-Tocilizumab 8mg/kg (maximum 800mg) once on Day 1. This is a single dose administration intravenously over 60 min infusion", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: RMP-Tocilizumab: RMP-Tocilizumab 8mg/kg (maximum 800mg) once on Day 1. This is a single dose administration intravenously over 60 min infusion", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]